| |
|
|
Recent NIH News
National Institutes of Health RECENT
NEWS |
Resveratrol Found to Improve Health, But Not Longevity in Aging Mice on Standard Diet
04 Jul 2008
Scientists have found that the compound resveratrol slows age-related deterioration and functional decline of mice on a standard diet, but does not increase longevity when started at middle age. This study, conducted and supported in part by the National Institute on Aging (NIA), part of the National Institutes of Health, is a follow-up to 2006 findings that resveratrol improves health and longevity of overweight, aged mice.
Broad Differences in Alcohol, Tobacco and Illegal Drug Use Across Countries
02 Jul 2008
A survey conducted by the World Health Organization (WHO) research consortium found that the United States had among the highest lifetime rates of tobacco and alcohol use and led in the proportion of participants reporting cannabis (marijuana) or cocaine use at least once during their lifetime. The study, led by Dr. Louisa Degenhardt of the University of New South Wales, Sydney, Australia and colleagues, looked at patterns in the use of alcohol, tobacco, cannabis and cocaine in 17 countries representing all six WHO regions (the Americas, Europe, Asia, the Middle East, Africa and Oceania). The study, funded in part by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) is published in the July 1, 2008 issue of the open access journal 'PLoS Medicine'.
Yeast-Based Vaccine Induces Immune Responses and Reduces Tumor Size in Mice
02 Jul 2008
Scientists have found that vaccination with a heat-killed, non-toxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice. Vaccination extends overall survival and reduces tumor size in mice that have been injected with cancer cells displaying the same protein that was engineered into the yeast. Results of this research by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, can be found in the July 1, 2008 issue of 'Clinical Cancer Research'.
NIAID Announces Grants to Stimulate Food Allergy Research
01 Jul 2008
Twelve investigators have received grants totaling $5 million over two years
to lead high-impact, innovative studies of food allergy, a significant public
health concern. This program, called Exploratory Investigations in Food Allergy,
is funded by the National Institute of Allergy and Infectious Diseases (NIAID),
part of the National Institutes of Health, and two advocacy groups, the Food
Allergy and Anaphylaxis Network (FAAN) and the Food Allergy Project (FAP).
Blocking a Single Protein Proves Toxic to Myeloma Cells in Laboratory Studies
26 Jun 2008
Researchers have found that cells from a blood-borne cancer called multiple myeloma rely on the activity of a single protein, called IRF4, for the activation of a wide range of genes responsible for cell survival and spread. Blocking the production of this protein can be strikingly effective in eliminating cancer cells in laboratory models of multiple myeloma. Scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), published their results in the June 22, 2008, issue of 'Nature', which highlight this potentially powerful new therapeutic target in multiple myeloma.
Scientists Isolate a Toxic Key to Alzheimer's Disease in Human Brains
26 Jun 2008
Scientists have long questioned whether the abundant amounts of amyloid plaques found in the brains of patients with Alzheimer's actually caused the neurological disease or were a by-product of its progress. Now, using new research techniques, scientists have shown that a two-molecule aggregate (or dimer) of beta-amyloid protein fragments may play a role in initiating the disease. The study, supported by the National Institutes of Health, suggests a possible new target for developing drug therapies to combat the irreversible and progressive disorder.
Study Shows That Small Protein Can Broaden Immune Response in Humans
26 Jun 2008
Treating cancer patients with interleukin-7 (IL-7), a small protein that can stimulate the immune system, leads to an increase in lymphocytes, key to the production of effective immune responses, in the body, according to a new study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). The demonstration that IL-7 is able to broaden the possible immune responses in humans could have a wide range of clinical implications. This study was published online June 23, 2008, in The 'Journal of Experimental Medicine'.
Newly Approved Ocular Safety Methods Reduce Animal Testing
26 Jun 2008
Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced today. ICCVAM is a permanent interagency committee composed of representatives from 15 federal regulatory and research agencies, including the National Institutes of Health (NIH) that use, generate or disseminate toxicology testing information.
NIAID Creates HIV Vaccine Discovery Branch to Promote Synergy between Basic HIV Researchers and Vaccine Designers
26 Jun 2008
To accelerate the translation of basic discoveries about HIV into advances in vaccine design and evaluation, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has formed a new Vaccine Discovery Branch within the Vaccine Research Program in the Division of AIDS (DAIDS).
Researchers Seek Participants for a Study of Antibiotic Use in Children with a Urinary Tract Disorder
21 Jun 2008
Researchers conducting a study to learn if children with a urinary tract disorder known as vesicoureteral reflux (VUR) should be treated with an antibiotic for an extended period of time are seeking to enroll more participants. The study, known as the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH).
|
|
More National Institutes of Health News From Archive
|
|
|
|
|
|
.jpg)
